MARKET

TERN

TERN

Terns Pharmaceuticals, Inc.
NASDAQ
2.880
+0.080
+2.86%
After Hours: 2.880 0 0.00% 16:19 04/23 EDT
OPEN
2.860
PREV CLOSE
2.800
HIGH
3.060
LOW
2.851
VOLUME
932.13K
TURNOVER
--
52 WEEK HIGH
11.40
52 WEEK LOW
1.865
MARKET CAP
251.42M
P/E (TTM)
-2.5772
1D
5D
1M
3M
1Y
5Y
1D
Monday Sector Leaders: Biotechnology, Drugs
NASDAQ · 2d ago
Weekly Report: what happened at TERN last week (0414-0418)?
Weekly Report · 2d ago
SA Asks: What's the best weight-loss drug stock right now?
Seeking Alpha · 6d ago
Terns Pharmaceuticals (TERN) Gets a Buy from Mizuho Securities
TipRanks · 04/15 10:17
Viking, Structure, Metsera on a tear as Pfizer drops obesity pill
Seeking Alpha · 04/14 15:03
Weekly Report: what happened at TERN last week (0407-0411)?
Weekly Report · 04/14 09:16
Terns Pharmaceuticals management to meet with Oppenheimer
TipRanks · 04/08 20:10
Weekly Report: what happened at TERN last week (0331-0404)?
Weekly Report · 04/07 09:16
More
About TERN
More
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Its product candidates in pipeline includes TERN-701, TERN-601 and TERN-501. TERN-701 is its oral, potent, allosteric BCR-ABL tyrosine kinase inhibitors (TKI) specifically targeting the ABL myristoyl pocket for CML, a form of cancer that begins in the bone marrow and leads to the growth of leukemic cells. TERN-601 is a small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist that is intended to be orally administered for obesity. TERN-501 is a thyroid hormone receptor beta (THR-b) agonist with high metabolic dysfunction-associated steatohepatitis (MASH). It is also focused on developing the TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity.
Recently
Symbol
Price
%Change

Webull offers Terns Pharmaceuticals Inc stock information, including NASDAQ: TERN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TERN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TERN stock methods without spending real money on the virtual paper trading platform.